The test results of swelling pressure of reinforced expansive soil. by Yonggang Huang (223155)

Subjects:

Influence of UHMWPE content on swelling pressure. by Yonggang Huang (223155)

Subjects:

Sampling point (Source: by Yonggang Huang (223155)

Subjects:

Enrichment Analysis Based on Ferroptosis-Related Differentially Expressed Genes. by Jiyong Zhang (2498740)

Subjects:

Correlation between hub genes and 50 hallmark signaling pathways. by Jiyong Zhang (2498740)

Subjects:

ROC curves for hub genes. by Jiyong Zhang (2498740)

Subjects:

Intersection genes obtained from the PPI network and PPI network analysis of intersection genes. colored circles represent genes. by Jiyong Zhang (2498740)

Subjects:

Expression profile heatmaps of key genes in gene sets. by Jiyong Zhang (2498740)

Subjects:

Influence of UHMWPE length on free swelling ratio. by Yonggang Huang (223155)

Subjects:

Construction of the WGCNA Co-expression Network. by Jiyong Zhang (2498740)

Subjects:

Influence of UHMWPE content on free swelling ratio. by Yonggang Huang (223155)

Subjects:

Soil partice-size distribution. by Yonggang Huang (223155)

Subjects:

Differential Gene Expression Associated with Non-Alcoholic Fatty Liver Disease. by Jiyong Zhang (2498740)

Subjects:

Interaction analysis of hub genes. by Jiyong Zhang (2498740)

Subjects:

Flowchart of the screening process. by Huixia Ren (500186)

“…Efficacy was assessed through intraoperative outcomes, primary postoperative outcomes, and statistically significant postoperative outcomes. Patients with thyroid disorders undergoing TOTVA experienced longer overall operative time and hospital stays, reduced intraoperative blood loss, increased lymph node retrieval, higher incidence of infection, lower postoperative pain scores, reduced incidence of hypocalcemia, larger drainage volumes, and higher cosmetic effect scores compared with those undergoing.…”

Result of the AMSTAR-2 assessments. by Huixia Ren (500186)

“…Efficacy was assessed through intraoperative outcomes, primary postoperative outcomes, and statistically significant postoperative outcomes. Patients with thyroid disorders undergoing TOTVA experienced longer overall operative time and hospital stays, reduced intraoperative blood loss, increased lymph node retrieval, higher incidence of infection, lower postoperative pain scores, reduced incidence of hypocalcemia, larger drainage volumes, and higher cosmetic effect scores compared with those undergoing.…”

Characteristics of included reviews. by Huixia Ren (500186)

“…Efficacy was assessed through intraoperative outcomes, primary postoperative outcomes, and statistically significant postoperative outcomes. Patients with thyroid disorders undergoing TOTVA experienced longer overall operative time and hospital stays, reduced intraoperative blood loss, increased lymph node retrieval, higher incidence of infection, lower postoperative pain scores, reduced incidence of hypocalcemia, larger drainage volumes, and higher cosmetic effect scores compared with those undergoing.…”

Result of the PRISMA assessments. by Huixia Ren (500186)

“…Efficacy was assessed through intraoperative outcomes, primary postoperative outcomes, and statistically significant postoperative outcomes. Patients with thyroid disorders undergoing TOTVA experienced longer overall operative time and hospital stays, reduced intraoperative blood loss, increased lymph node retrieval, higher incidence of infection, lower postoperative pain scores, reduced incidence of hypocalcemia, larger drainage volumes, and higher cosmetic effect scores compared with those undergoing.…”

Result of the ROBIS assessments. by Huixia Ren (500186)

“…Efficacy was assessed through intraoperative outcomes, primary postoperative outcomes, and statistically significant postoperative outcomes. Patients with thyroid disorders undergoing TOTVA experienced longer overall operative time and hospital stays, reduced intraoperative blood loss, increased lymph node retrieval, higher incidence of infection, lower postoperative pain scores, reduced incidence of hypocalcemia, larger drainage volumes, and higher cosmetic effect scores compared with those undergoing.…”

A higher proportion of active KRAS exhibit greater sensitivity to daraxonrasib. by Okkeun Jung (21243431)